Heart Failure Summit
- Continuing Education
Explore comprehensive, multidisciplinary strategies for managing heart failure—from outpatient care to advanced therapies—through expert-led sessions, case studies, and patient perspectives in this Harvard Medical School–accredited one-day summit.
- In Person
This course is taught in person.
Additionally, all sessions will be recorded and made available to participants for on-demand online viewing for 30 days after the end of the course.
The Westin Waltham | 70 3rd Ave, Waltham, MA
$175
For a full list of profession pricing see below.
View All
Continuing Education
Earn up to:
6.00 AMA PRA Category 1 Credits™.
View All
One Day
Please view the Schedule for a full description of the program.
On This Page
Overview
Heart Failure Summit, accredited by Harvard Medical School, will offer a one-day overview of all aspects of heart failure management from outpatient monitoring to left ventricular assist device implantation and cardiac transplantation. Faculty from multiple disciplines will review current guidelines and potential therapies for advanced heart failure. The course will provide case studies illustrating different approaches to pharmacological and device management. Participants will also hear patient and caregiver perspectives on therapies for advanced heart failure.
Learning Objectives
- Outline current outpatient management strategies for advanced heart failure including novel pharmacologic treatments, home monitoring, and advanced care planning.
- Review current pharmacologic approaches to treatment and their practical implementation.
- Review innovative techniques, surgical considerations, and expected outcomes for patients undergoing heart transplantation.
- Share patient and caregiver perspectives on living with advanced heart failure.
- Discuss representative case examples to demonstrate the use of mechanical support, including ventricular assist devices (VADs) to improve survival and quality of life as a bridge to heart transplantation (BTT) or destination therapy (DT).
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Beth Israel Deaconess Medical Center.
Who Should Participate
Physician Assistants, Nurses, Pharmacists, Other, Primary Care Physicians, Specialty Physicians, Nurse Practitioners
Physical Therapists, Nutritionists, and Trainees (Residents and Fellows)
Schedule
All agenda sessions are in Eastern Time.
Friday, January 29, 2027
Registration and Breakfast
8:00-8:25 am
Introduction
8:25-8:30 am
KeyNote Speaker: Updates in Advanced Heart Failure
8:30-9:00 am
Session #1
9:00-10:40 am
Inherited CMP; Genetics of Inherited Cardiomyopathies
9:00-9:20 am
Inherited CMP; Risk stratification and Devices in Inherited Cardiomyopathies
9:20-9:40 am
Inherited CMP; Advanced HF Options in Inherited Cardiomyopathies
9:40-10:00 am
Inherited CMP; Patient panel/discussion of Inherited CMP session
10:00-10:40 am
Break #1
10:40-11:00 am
Session #2
11:00 am-12:00 pm
Challenging cases in HF; Case of cardiac amyloidosis
11:00-11:30 am
Challenging cases in HF; Cardio-oncology case
11:30 am-12:00 pm
Lunch break
12:00-1:00 pm
Debate
1:00-1:30 pm
Patient panel discussion
1:30-2:00 pm
Break #2
2:00-2:20 pm
Basics of POCUS
2:20-3:20 pm
Hemodynamics Crashcourse
2:20-3:20 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Marwa Sabe
MD, MPH, FACC | Course Director
- Associate Director, Section of Advanced Heart Failure, MCS, and Heart Transplant
- Director, Ventricular Assist Device Program, Beth Israel Deaconess Medical Center
David Venesy
MD | Course Director
- Director, Advanced Heart Failure and Cardiomyopathy Program, Lahey Hospital & Medical Center
Lisa Fleming
MD, MPH | Course Director
- Advanced Heart Failure and Transplant Cardiologist, Atrius Health
Dana Price
MD | Course Director
- Advanced Heart Failure and Transplant Cardiologist, Lahey Hospital & Medical Center
Jessie Breed, MSN, RN
Director, Heart Transplant and Specialty Programs, Beth Israel Deaconess Medical Center
James Fang, MD
Chief of Cardiovascular Medicine, University of Utah School of Medicine
Director of the Cardiovascular Service Line, University of Utah Health Care
A. Reshad Garan, MD, MS, FACC
Section Chief, Advanced Heart Failure and MCS, Beth Israel Deaconess Medical Center
Eli Gelfand, MD
Section Chief, General Cardiology, Beth Israel Deaconess Medical Center
Jan Griffin, MD
Director of the Cardiac Amyloidosis Program, Beth Israel Deaconess Medical Center
Sonia Kothari, PharmD, BCPS, BCCP
Clinical Pharmacy Specialist, Beth Israel Deaconess Medical Center
Pablo Quintero, MD
Medical Director, Heart Transplant Program, Beth Israel Deaconess Medical Center
Usman Tahir, MD
Director, Center for Cardiovascular Genetics
Co-Director, Hypertropic Cardiomyopathy Clinic, Beth Israel Deaconess Medical Center
Jenica Upshaw, MD, MSc
Section Head of Cardio-Oncology and Heart Failure Research
Director, Cardio-Oncology Program, Beth Israel Deaconess Medical Center
Peter Zimetbaum, MD
Clinical Director and Associate Chief of Cardiology, Beth Israel Deaconess Medical Center
Complete Your Registration
Started a registration? Log in to enroll today.
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Registration Details
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus, and access to some recordings for 30 days after the course. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $175 |
| Nurse (RN/APRN) | $125 |
| Industry | $250 |
| Nurse Practitioner (NP) | $125 |
| PA | $125 |
| Pharmacist | $125 |
| Resident/Fellow | $75 |
BILH Residents and fellows can attend for free, contact CardioVascularInstitute@bidmc.harvard.edu for more info.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 6.00 ANCC contact hour(s).
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Harvard Medical School designates this knowledge-based activity for a maximum of 6.00 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.